CLCN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.762600E-01
Normal-vs-Stage2
6.211000E-01
Normal-vs-Stage3
3.612600E-01
Normal-vs-Stage4
1.677980E-01
Stage1-vs-Stage2
5.846600E-01
Stage1-vs-Stage3
7.305600E-02
Stage1-vs-Stage4
2.775400E-01
Stage2-vs-Stage3
4.699800E-03
Stage2-vs-Stage4
4.319600E-02
Stage3-vs-Stage4
6.097500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.510800E-01
Normal-vs-AfricanAmerican
2.924000E-01
Normal-vs-Asian
8.356800E-01
Caucasian-vs-AfricanAmerican
1.218440E-01
Caucasian-vs-Asian
6.617200E-01
AfricanAmerican-vs-Asian
1.565350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.262600E-01
Normal-vs-Female
6.119200E-01
Male-vs-Female
9.297400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.595400E-01
Normal-vs-Age(41-60Yrs)
4.362400E-01
Normal-vs-Age(61-80Yrs)
7.023600E-01
Normal-vs-Age(81-100Yrs)
9.473600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.154600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.848200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.826800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.268100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.132610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.818400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.417800E-01
Normal-vs-Daily Drinker
7.669000E-01
Normal-vs-Weekly Drinker
9.964000E-01
Normal-vs-Occasional Drinker
4.220400E-01
Normal-vs-Social Drinker
3.840600E-01
Non Drinker-vs-Daily Drinker
4.259000E-01
Non Drinker-vs-Weekly Drinker
8.904800E-01
Non Drinker-vs-Occasional Drinker
8.315900E-02
Non Drinker-vs-Social Drinker
5.678000E-02
Daily Drinker-vs-Weekly Drinker
6.330600E-01
Daily Drinker-vs-Occasional Drinker
2.603600E-02
Daily Drinker-vs-Social Drinker
1.978280E-02
Weekly Drinker-vs-Occasional Drinker
1.593840E-01
Weekly Drinker-vs-Social Drinker
1.272400E-01
Occasional Drinker-vs-Social Drinker
7.938800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.006630E-01
Normal-vs-Grade 2
3.732200E-02
Normal-vs-Grade 3
2.685900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.112000E-01
Grade 1-vs-Grade 3
6.707400E-01
Grade 1-vs-Grade 4
1.006630E-01
Grade 2-vs-Grade 3
4.521200E-01
Grade 2-vs-Grade 4
3.732200E-02
Grade 3-vs-Grade 4
2.685900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.013000E-01
Normal-vs-NonDiabetic
6.931200E-01
Diabetic-vs-NonDiabetic
6.723600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.645800E-01
Normal-vs-NoPancreatitis
6.884600E-01
Pancreatitis-vs-NoPancreatitis
7.791600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.009000E-01
Normal-vs-N1
6.031800E-01
N0-vs-N1
7.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.822800E-01
Normal-vs-TP53-NonMutant
3.850800E-01
TP53-Mutant-vs-TP53-NonMutant
8.914200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
